Abstract:Despite considerable progress in genome- and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did not match the increase of drug development costs. Network description and analysis not only give a systems-level understanding of drug action and disease complexity, but can also help to improve the efficiency of drug design. We give a comprehensive assessment of the analytical tools of network topology and dynamics. The state-of-the-art use of chemical similarity, protein structure, protein-protein interaction, signaling, genetic interaction and metabolic networks in the discovery of drug targets is summarized. We propose that network targeting follows two basic strategies. The central hit strategy selectively targets central nodes/edges of the flexible networks of infectious agents or cancer cells to kill them. The network influence strategy works against other diseases, where an efficient reconfiguration of rigid networks needs to be achieved by targeting the neighbors of central nodes or edges. It is shown how network techniques can help in the identification of single-target, edgetic, multi-target and allo-network drug target candidates. We review the recent boom in network methods helping hit identification, lead selection optimizing drug efficacy, as well as minimizing side-effects and drug toxicity. Successful network-based drug development strategies are shown through the examples of infections, cancer, metabolic diseases, neurodegenerative diseases and aging. Summarizing more than 1200 references we suggest an optimized protocol of network-aided drug development, and provide a list of systems-level hallmarks of drug quality. Finally, we highlight network-related drug development trends helping to achieve these hallmarks by a cohesive, global approach.

How to design multi-target drugs: Target search options in cellular networks

Computational Multitarget Drug Design.

In-Silico Approaches to Multi-target Drug Discovery

Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review

Computer Aided Multi-target Drug Design, Multi-target Virtual Screening

Network Pharmacology: Exploring the Resources and Methodologies.

Recent Advances in the Rational Drug Design Based on Multi-target Ligands.

Recent advances and method development for drug target identification

Recent Advances In The Rational Drug Design Based On Multi-Target Ligands

What are the challenges with multi-targeted drug design for complex diseases?

Multiple target-based pharmacophore design from active site structures

Application Advances on Novel Techniques in Multi-target Drugs Discovery

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning

Drug-therapy networks and the predictions of novel drug targets

Recent Advances on the Network Models in Target-based Drug Discovery

Drug—target network

[Drug Targets Discovery Based on Dynamic Signal Transduction Networks].

[Multi-Target Therapeutics and New Drug Discovery].

Recent advances in multitarget-directed ligands via in silico drug discovery

Network-Based Methods and Their Applications in Drug Discovery

Molecular hybridization: a powerful tool for multitarget drug discovery